21 – 30 of 104
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
CRISPR Screens Identify Candidate Therapeutic Targets in Leukemia
2023) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Priorities in Cardio-Oncology Basic and Translational Science : GCOS 2023 Symposium Proceedings: JACC: CardioOncology State-of-the-Art Review
(
- Contribution to journal › Scientific review
-
Mark
Неоадъювантная химиоиммунотерапия у пациентов раком желудка с микросателлитной нестабильностью
(
- Contribution to journal › Article
-
Mark
HLA Class I Genotype Is Associated with Relapse Risk after Allogeneic Stem Cell Transplantation for NPM1-Mutated Acute Myeloid Leukemia
(
- Contribution to journal › Article
-
Mark
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma : 2023 Update
(
- Contribution to journal › Scientific review
-
Mark
ATOR-1017 (evunzekibart), an Fc-gamma receptor conditional 4-1BB agonist designed for optimal safety and efficacy, activates exhausted T cells in combination with anti-PD-1
(
- Contribution to journal › Article
-
Mark
Editorial : Biomarkers in the era of cancer immunotherapy: zooming in from the periphery to the tumor microenvironment
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Efficacy of immune checkpoint inhibitors in alveolar soft-part sarcoma : results from a retrospective worldwide registry
(
- Contribution to journal › Article
- 2022
-
Mark
Landscape of surfaceome and endocytome in human glioma is divergent and depends on cellular spatial organization
2022) In Proceedings of the National Academy of Sciences of the United States of America 119(9). p.1-11(
- Contribution to journal › Article
-
Mark
The immune cell atlas of human neuroblastoma
(
- Contribution to journal › Article